In agreement with our findings, the prevention of insulin resistance and obesity induced by oltipraz in diabetic mice and the inhibition of neuropathic pain induced by sulforaphane in nerve-injured animals are also mediated by triggering the Nrf2/HO-1 pathway [31,37]. Here, HMOX1 is linked to obesity disorder.